Video Library

CAR T cell therapy is a new type of therapy for patients with multiple myeloma. It is currently available for patients who have relapsed after four or more rounds prior therapy. This presentation describes CAR T cell and related therapies as well as new drugs in the pipeline to treat patients with multiple myeloma

Anxiety and depression are common among cancer patients and survivors. Acceptance and commitment therapy is an effective tool for these problems. This presentation discusses the mental health challenges of transplant and GVHD patients and how this therapy can help them.

Sickle cell disease disproportionately affects African Americans. However, stem cell transplants and gene therapy offer promising treatment options. This presentation describes these treatments, their outcomes, and which treatments are appropriate for which patients.

Occupational therapists can help transplant recipients manage their fatigue, and redesign their lifestyle to improve quality of life, while recovering transplant and side effects such as graft-versus-host disease (GVHD).

Puntos clave: 19:17 Tener la enfermedad de injerto contra huésped es un factor de riesgo adicional de COVID-19. 23:31 Los tratamientos para los casos leves se manejan mejor en casa

It is now my pleasure to introduce your host, Susan Stewart. Susan Stewart ( 00:00:05): Introductions Thank you very much, and welcome to the COVID-19 Winter Update: What Transplant Recipients

Chronic ocular graft-versus-host disease (GVHD) affects more than 50% of patients who have chronic GVHD. A variety of therapies are available and should be approached in a step-ladder manner.

The immune system fights both infection and cancer. When cancer cells evade the immune system, the patient's T-cells, which are part of the immune system, can be genetically engineered to fight the cancer cells. This is called CAR T cell therapy.

Bone marrow and peripheral blood stem cell transplants are a potential cure for many people with a life-threatening disease. Family members may be tested to determine if they can donate bone marrow or peripheral blood stem cells (PBSCs) to a relative who needs a transplant. This presentation reviews the procedures, risks, benefits and safety of donating bone marrow or PBSCs to a relative.